NewLink Genetics Corp (NASDAQ:NLNK)

53.71
Delayed Data
As of Apr 17
 -0.79 / -1.45%
Today’s Change
17.32
Today|||52-Week Range
58.73
+35.12%
Year-to-Date

Today’s Trading

Previous close54.50
Today’s open54.04
Day’s range53.05 - 54.77
Volume391,922
Average volume (3 months)539,030
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-157.83%
Earnings growth (next 5 years)--
Revenue growth (last year)+15,690.67%
P/E ratio16.2
Price/Sales6.41
Price/Book7.37

Competitors

 Today’s
change
Today’s
% change
ZIOPZIOPHARM Oncology In...-0.04-0.29%
FWPForward Pharma A/S+0.16+0.50%
USNAUSANA Health Science...-2.72-2.25%
CMRXChimerix Inc-1.24-3.12%
Data as of 4:02pm ET, 04/17/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$172.6M
Annual profit (last year)$102.9M
Net profit margin59.60%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers